Navigation Links
Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
Date:1/15/2014

LAVAL, Quebec, Jan. 15, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with respect to the previously announced tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all of the outstanding shares of common stock of Solta Medical, Inc. (NASDAQ: SLTM) ("Solta") at a price of $2.92 per share, net to the seller in cash, without interest (less any required withholding taxes) and subsequent merger of Purchaser with Solta expired at 11:59 p.m., New York City time on January 14, 2014.  The expiration of the HSR waiting period satisfies one of the conditions to consummate the tender offer.

About Valeant Pharmaceuticals International, Inc.

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology, and branded generics.  More information about Valeant Pharmaceuticals International, Inc. can be found at www.valeant.com.

Forward-Looking Statements

This press release may contain forward-looking statements regarding, among other things, the proposed acquisition by Valeant of Solta and expected timing of the transaction.  Because these statements reflect Valeant's current views, expectations and beliefs concerning future events, these forward-looking statements involve risks and uncertainties.  Investors should note that many factors could affect the proposed business combination of the
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
2. Valeant Pharmaceuticals To Present At Industry Conferences
3. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
4. Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
5. Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes
6. Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016
7. Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results
8. Valeant Pharmaceuticals Announces Settlement Agreement With Anacor
9. Valeant Pharmaceuticals Announces Partnership With National Coalition Against Domestic Violence
10. Valeant Pharmaceuticals Announces Continuance
11. Valeant Pharmaceuticals Reports 2013 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... Former NASA scientist Tamim Hamid ... he discussed Theradome™, the first portable and wearable OTC ... shows firsthand how, via laser technology, Theradome™ offers individuals ... will not require surgery or medication.  ... of the hair follicle, which is where the stem ...
(Date:5/4/2015)... PAREXEL International Corporation (NASDAQ: PRXL ) announced ... Conference on Monday, May 18, 2015, in New York City.  ... Officer will be making a presentation on PAREXEL and discussing ... webcast of the presentation will be available through the "Investors" ... Upcoming Events portion of the main page, and a replay ...
(Date:5/4/2015)... May 4, 2015 Rogne Bioscience, a privately-held ... announced that preclinical and mechanism of action data will ... of Investigative Dermatology (SID) Annual Meeting being held May ... Atlanta, Georgia . Logo - http://photos.prnewswire.com/prnh/20150501/213318LOGO ... of RON2315, a novel, low MW (<1700 daltons) peptide ...
Breaking Medicine Technology:FOX News Features Theradome as the Take-Home Solution to Tackle Baldness 2PAREXEL International to Present at UBS Healthcare Conference 2Rogne Bioscience to Present Data from Topical Biologic Psoriasis Program at Upcoming SID Annual Meeting 2015 2
... U.S. Food and Drug Administration today announced steps to ... devices that can lead to the transmission of disease. ... Medical devices intended for repeated use are commonplace ... durable substances that can withstand reprocessing, a multistep process ...
... (NASDAQ: KOOL ), a leading supplier of innovative ... will report financial results for the fiscal third quarter ended March ... Company,s Conference Call and Webcast Management ... PM Pacific (5:00 PM Eastern) to review the fiscal third quarter ...
Cached Medicine Technology:FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 2FDA Looks to Improve Design and Cleaning Instructions for Reusable Medical Devices 3ThermoGenesis Corp. to Announce Third Quarter Fiscal 2011 Results On May 5, 2011 2
(Date:5/4/2015)... NY (PRWEB) May 05, 2015 ... honors Irene Taylor , Volunteer Executive ... as a 2015-2016 inductee into its VIP Woman ... this prestigious distinction for leadership in business. NAPW ... professional women, boasting more than 700,000 members and ...
(Date:5/4/2015)... City, NY (PRWEB) May 05, 2015 ... honors Jennifer Yates Doherty as a 2015-2016 ... Circle. She is recognized with this prestigious distinction for ... organization exclusively for professional women, boasting more than 700,000 ... pleased to welcome Jennifer into this exceptional group of ...
(Date:5/4/2015)... (PRWEB) May 05, 2015 The ... Shirley Weis as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in healthcare. NAPW ... women, boasting more than 700,000 members and over 200 ... with this important honor,” says NAPW President Star Jones. ...
(Date:5/4/2015)... 04, 2015 The American Council ... Thomopulos, P.E., Chairman of Stanley Consultants , to ... of directors for a three-year term. , ACEC co-established ... the American Society of Civil Engineers (ASCE). A ... system for civil infrastructure called Envision. Launched in 2012, ...
(Date:5/4/2015)... HHT is a rare but cruel and unrelenting ... have seemingly mild symptoms like frequent nosebleeds, it can ... Telangiectasia (HHT) is a hereditary disorder resulting in the ... between an artery and a vein. These abnormalities in ... also be present in the lungs, brain and liver. ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Irene Taylor into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Jennifer Yates Doherty, Owner of Palmetto Rehabilitation Services, LLC, into its 2015 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Shirley Weis, President at Weis Associates, LLC, into its 2015-2016 VIP Woman of the Year Circle 3Health News:Thomopulos Appointed to Institute for Sustainable Infrastructure Board 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 2Health News:Frequent Nosebleeds Can Be a Sign of a Rare Undiagnosed Disease - Cure HHT 3
... fetal surgery and the cause of heated debate among ... the best way to treat twin-twin transfusion syndrome (TTTS), ... and the leading cause of mortality in twins? ... 17 centers in the United States, will be presented ...
... gift that brought tears to the receiver and to the ... was pledged to the staff at Toronto’s Hospital for Sick Children ... of a beer baron and well-established friend of the hospital. ... mutual fund company and his wife Sonia, have pledged this amount ...
... to the flu, in British Columbia//. , The flu season ... of December and January. ,This unusually long delay may ... Theresa Tam of the Public Health Agency of Canada, in an average ... year that can go up to six to eight thousand. ...
... hospitals with a fewer infection and death rates is announced ... method// has been tried out successfully in United States. This ... of society. ,The incentive scheme initially is set ... knee replacements. In case of very sick patients and severe ...
... is a complex and common disease caused by a ... research shows that the constitutional mutation in PALB2 gene ... ,Previous studies have shown that genes are responsible for ... breast cancer. The two major familial breast cancer susceptibility ...
... unique weaving machine of their design, Duke University Medical ... could greatly improve the ability of physicians to repair ... ,"If further experiments are successful, the scaffold ... four years," said Franklin Moutos, a graduate student in ...
Cached Medicine News:Health News:Timeliness, a Critical Factor in Treating TTTS 2Health News:Timeliness, a Critical Factor in Treating TTTS 3Health News:Record Donation to Children’s Hospita 2Health News:Flu Strikes Late - Child Succumbs 2Health News:Mutation In PALB2 Elevates Risk of Cancer 2Health News:Woven Cartilage 2
... Esprit is an internationally known ... youthful image. The ophthalmic collection offers ... originality and creativity in titanium, metal ... line features unique styling with trendy ...
The license agreement for the manufacturing and distribution of Bulgari eyewear was signed by Luxottica Group in 1997.,Bulgari eyewear is designed for sleek, select people who want to distinguish the...
... collection features classic designs paired with modern, ... range of materials including ultra-light titanium to ... as ovals, almonds and squares. Three-piece mounts ... The sun wear collection is the perfect ...
The Aristar collection offers high quality, fashionable eyewear at exceptional pricing. Classic shapes updated with contemporary designs allow both men and women alike to enjoy superior craftsmanship...
Medicine Products: